Concepedia

Receptor Tyrosine Kinase Expression Predicts Response to Sunitinib in Breast Cancer

Philip M. Spanheimer, Allison W. Lorenzen, James P. De Andrade, Mikhail V. Kulak, Jennifer C. Carr, George W. Woodfield, Sonia L. Sugg, Ronald J. Weigel

Annals of Surgical Oncology · 2015 · 29 citations · 18 references

DOIFull text

Open access

Concepts

References

18

Cancer statistics, 2013

Rebecca L. Siegel, Deepa Naishadham, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2013 · 11.9K citations · Full text

, , +16

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Thérese Sørlie, Charles M. Perou, Robert Tibshirani et al. · Proceedings of the National Academy of Sciences · 2001 · 10.9K citations · Full text

, , +16

Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy

Roman Rouzier, Charles M. Perou, W. Fraser Symmans et al. · Clinical Cancer Research · 2005 · 1.9K citations · Full text

, , +17

First-Line Treatment of Advanced Breast Cancer With Sunitinib in Combination With Docetaxel Versus Docetaxel Alone: Results of a Prospective, Randomized Phase III Study

Jonas Bergh, Mikhail Lichinitser, Annelie Liljegren et al. · Journal of Clinical Oncology · 2012 · 262 citations · Full text

, , +15

The Ret Receptor Tyrosine Kinase Pathway Functionally Interacts with the ERα Pathway in Breast Cancer

Anne Boulay, Madlaina Breuleux, Christine Stephan et al. · Cancer Research · 2008 · 124 citations · Full text

, , +17